News | X-Ray | November 19, 2021

Company will be exhibiting at 2021 RSNA Scientific Assembly and Annual Meeting

Reveal 35C is the world’s first single exposure portable dual-energy X-ray detector.

November 19, 2021 — “Data drive decisions and with the latest trial data, we are positioned for growth,” said Amol Karnick, president and CEO of KA Imaging. In a paper presented earlier this year, the Reveal 35C technology was shown to detect 25% more pneumonia cases (including COVID-19) than traditional X-Ray.1

Reveal 35C is the world’s first single exposure portable dual-energy X-ray detector. Reveal is retrofittable and can be called a detector-side dual-energy upgrade: simply by replacing the detector, any existing X-ray system can be upgraded to dual-energy. With the same radiation dose as a chest X-ray, it creates three images without motion artifacts (standard digital X-ray, soft tissue and bone), giving the ability to see the lungs and soft tissue without having bones obstructing the view.

The paper presents the initial results of an ongoing clinical trial that is being carried out in Toronto, Canada. “Although Reveal has been available for sale in both the U.S. and Canada for the past year, we have enrolled Reveal in a number of clinical trials to demonstrate the significant improvement in clinical outcomes compared to standard digital X-ray,” said Karnick.

According to the company, Reveal 35C enhances the use of dual energy, benefiting not only radiologists, but the entire service chain.

“It’s good for radiologists, who can access supplementary dual energy X-ray images for faster and easier reading,” explained Karnick. “It’s good for imaging technologists, who can offer patients more comfort by bringing the detector to the point of care and getting high-quality images even in challenging settings such as critical care units; it's good for administrators, who can optimize the use of other equipment across multiple departments; and it is especially good for patients, who have more comfort and early access to treatment for diseases that could go unnoticed until they become more serious,” he concluded.

KA Imaging at RSNA

KA Imaging is exhibiting at 2021 RSNA Scientific Assembly and Annual Meeting. The company is located at booth 6544 in McCormick Place’s North Hall level 3.

For more information: www.kaimaging.com

Reference:

1 Sanchez F, Kandel S, May M, Ronghe S, Rogalla P. Diagnostic value of dual-energy chest X-ray in immunocompromised patients to rule out pneumonia: initial results. European Congress of Radiology-ECR 2021, 2021.

Additional RSNA21 conference coverage can be found here.

Related Content

Feature | Radiology Imaging | By Melinda Taschetta-Millane

December 8, 2021 — Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of November ...

Time December 08, 2021
arrow
Videos | Artificial Intelligence

Sanjay Parekh, Ph.D., Signify Research senior market analyst, explains some of the recent trends in the application of ...

Time December 08, 2021
arrow
News | PACS

December 8, 2021 — IMAGE Information Systems, headquartered in Rostock, Germany, and aycan Medical Systems ...

Time December 08, 2021
arrow
News | Digital Radiography (DR)

December 8, 2021 — At RSNA 2021, Agfa launched its new VALORY digital radiography (DR) room. VALORY delivers a simple ...

Time December 08, 2021
arrow
News | Digital Radiography (DR)

December 8, 2021 — Carestream Health’s mobile diagnostic X-ray systems help Franciscan Health Crawfordsville, a 103-bed ...

Time December 08, 2021
arrow
News | Computed Tomography (CT)

December 7, 2021 — Xoran Technologies was recently awarded a grant from the National Heart, Lung, and Blood Institute ...

Time December 07, 2021
arrow
News | Information Technology

December 7, 2021 — Sirona Medical, a software company founded on a deep understanding of both the practice and business ...

Time December 07, 2021
arrow
News | Clinical Trials

December 7, 2021 — IceCure Medical Ltd., developer of minimally-invasive cryoablation technology, the ProSense System ...

Time December 07, 2021
arrow
News | Molecular Imaging

December 7, 2021 — Orviglance* is a novel manganese-based oral contrast agent for magnetic resonance imaging (MRI) ...

Time December 07, 2021
arrow
News | Breast Imaging

December 7, 2021 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), screening ...

Time December 07, 2021
arrow
Subscribe Now